Additionally, Kaplan-Meier analysis of OS in 100 GC patients revealed that the patients with high expression of LOX-1 showed shorter OS than patients with low LOX-1 expression (P < 0.001; Fig. 2d), which was consistent with the data from database GSE15459 (P < 0.001; Fig. 2e). Here, OLR1 is linked to gastric cancer.